Tagline
Positively Transforming The Lives of Airways Disease Patients
Overview
Vectura was established in 1997 to identify and develop opportunities in drug formulation and delivery. Vectura has evolved into a product development company that focuses on the development of pharmaceutical therapies for airways diseases.With our extensive range of technologies, capabilities, and collaborations, we believe we can become a leader in the development of inhalation products, increasing our ability to help patients suffering from respiratory diseases worldwide.
Company Services
Services/CapabilitiesCDMO
+ Development Services
- Analytical Development & Validation
- Preformulation/Formulation
- Process Development & Validation
- Scale Up/Tech Transfer
+ Drug Product Manufacturing
- Liquid/Semi-Solid Dosage Manufacturing (Non Sterile liquid, creams, ointments)
Regulatory/CertificationsCDMO
Focus Area/Product TypeCDMO
+ Biosimilars
+ Drug Delivery /Formulation
+ Generics